J. Wagner

发表

Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.

M. Hoenigl, R. Krause, R. Raggam, 2014, Medical mycology.

Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial

C. Schade-Brittinger, K. Rabe, A. Günther, 2017, BMC Pulmonary Medicine.

The use of electronic nose technology for the detection of Lung Cancer (LC): analysis of exhaled volatile compounds by Aeonose®

W. Seeger, A. Guenther, M. Degen, 2018, Lung Cancer.

Serum and urine galactomannan testing for screening in patients with hematological malignancies.

M. Hoenigl, R. Krause, A. Wölfler, 2014, Medical mycology.

Research update for articles published in EJCI in 2013

R. Abbate, B. Miazgowski, T. Miazgowski, 2015, European journal of clinical investigation.

Performance of Galactomannan, Beta-d-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis

M. Hoenigl, R. Krause, C. Thornton, 2014, Journal of Clinical Microbiology.

Performance of Galactomannan , Beta-D-Glucan , 1 Aspergillus Lateral-Flow Device , Conventional Culture 2 and PCR tests for Diagnosis of Invasive Pulmonary 3 Aspergillosis in Bronchoalveolar Lavage Fluid

M. Hoenigl, R. Krause, C. Thornton, 2014 .

Aspergillosis for Diagnosis of Invasive Pulmonary Tests with Bronchoalveolar Lavage Fluid Device , Conventional Culture , and PCR Beta-d-Glucan , Aspergillus Lateral-Flow Performance of Galactomannan

R., A., M. Hoenigl, 2014 .

Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies

M. Hoenigl, R. Krause, R. Raggam, 2013, Antimicrobial Agents and Chemotherapy.

Activated protein C resistance assay and factor V Leiden.

W. März, W. Renner, E. Weiss, 2014, The New England journal of medicine.

Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients.

M. Hoenigl, R. Krause, C. Thornton, 2012, The Journal of infection.

Feasibility of testing three salivary stress biomarkers in relation to naturalistic traffic noise exposure.

Michael Cik, Egon Marth, Eugen Gallasch, 2010, International journal of hygiene and environmental health.

Evaluation of a novel standardized system for collection and quantification of oral fluid

R. Raggam, E. Stelzl, H. Kessler, 2008, Clinical chemistry and laboratory medicine.

Reliable detection and quantitation of viral nucleic acids in oral fluid: Liquid phase‐based sample collection in conjunction with automated and standardized molecular assays

R. Stauber, R. Raggam, H. Kessler, 2008, Journal of medical virology.

Amoebic liver abscess in travellers: indication for image-guided puncture?

M. Hoenigl, R. Krause, R. Raggam, 2012, Wiener klinische Wochenschrift.

Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy

M. Hoenigl, R. Krause, A. Wölfler, 2013, Mycoses.

Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies.

M. Hoenigl, R. Krause, R. Raggam, 2014, International journal of antimicrobial agents.

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis

W. Seeger, W. Klepetko, A. Wells, 2018, Respiratory Research.

Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome.

E. Leitner, M. Hoenigl, R. Krause, 2013, Clinical biochemistry.

Autochthonous Leptospirosis in South-East Austria, 2004–2012

F. Allerberger, M. Hoenigl, R. Krause, 2014, PloS one.

Microbiological screening for earlier detection of central venous catheter–related bloodstream infections

P. Neumeister, M. Hoenigl, R. Krause, 2013, European journal of clinical investigation.

Characteristics of Hospital-Acquired and Community-Onset Blood Stream Infections, South-East Austria

E. Leitner, M. Hoenigl, R. Krause, 2014, PloS one.

Clinical Evaluation of Multiple Inflammation Biomarkers for Diagnosis and Prognosis for Patients with Systemic Inflammatory Response Syndrome

M. Hoenigl, R. Krause, R. Raggam, 2014, Journal of Clinical Microbiology.

Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome

E. Leitner, M. Hoenigl, R. Krause, 2014, Journal of internal medicine.

Clinical characteristics of patients with unclassifiable interstitial lung disease

A. Wells, A. Guenther, C. Vancheri, 2015 .

Response Syndrome for Patients with Systemic Inflammatory Biomarkers for Diagnosis and Prognosis Clinical Evaluation of Multiple Inflammation

M. Hoenigl, R. Krause, R. Raggam, 2014 .

Detection and quantitation of Epstein-Barr virus (EBV) DNA in EDTA whole blood samples using automated sample preparation and real time PCR

R. Raggam, H. Kessler, C. Homberg, 2010, Clinical Chemistry and Laboratory Medicine.

Bacteraemia with rifampin-resistant Staphylococcus aureus and the potential role of cross-resistance between rifampin and rifaximin.

M. Hoenigl, R. Krause, I. Zollner-Schwetz, 2014, The Journal of infection.

Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies

M. Hoenigl, R. Krause, R. Raggam, 2013, Antimicrobial Agents and Chemotherapy.

Serum and urine galactomannan testing for screening in patients with hematological malignancies.

M. Hoenigl, R. Krause, A. Wölfler, 2014, Medical mycology.